Faruqi & Faruqi, LLP Is Seeking More Cash For The Shareholders Of BioMimetic Therapeutics Inc. (BMTI)
20 Novembre 2012 - 1:01AM
Business Wire
Faruqi & Faruqi, LLP, a leading national securities firm
headquartered in New York City, is investigating the Board of
Directors of BioMimetic Therapeutics Inc. (“BioMimetic” or the
“Company”) (NASDAQ: BMTI) for potential breaches of fiduciary
duties in connection with their conduct related to the sale of the
Company to Wright Medical Group Inc. (“WMGI”) (NASDAQ: WMGI) in a
cash-and-stock deal valued at approximately $380 million. Under the
terms of the proposed transaction, BioMimetic’s stockholders will
receive $1.50 in cash and 0.2482 of a WMGI share for each share of
BioMimetic common stock they own. The transaction values the
proposed consideration at approximately $6.47 based on WMGI’s
closing stock price on Friday, November 16, 2012, while according
to Yahoo! Finance, at least one financial analyst has set a price
target of $7.50 for BioMimetic.
Request more information now by clicking here:
www.faruqilaw.com/BMTI. There is no cost or
obligation to you.
The investigation focuses on whether BioMimetic’s Board of
Directors breached their fiduciary duties to the Company’s
stockholders by failing to conduct an adequate and fair sales
process prior to agreeing to this proposed transaction, whether and
by how much this proposed transaction undervalues the Company to
the detriment of BioMimetic’s shareholders.
Faruqi & Faruqi, LLP is a national law firm which represents
investors and individuals in class action litigation. The firm is
focused on providing exemplary legal services in complex litigation
in the areas of securities, shareholder, antitrust and consumer
litigation, throughout all phases of litigation. The firm has an
experienced trial team which has achieved significant victories on
behalf of the firm’s clients.
If you own common stock in BioMimetic and wish to obtain
additional information and protect your investments free of charge,
please visit us at www.faruqilaw.com/BMTI or contact Juan E.
Monteverde, Esq. either via e-mail at jmonteverde@faruqilaw.com or
by telephone at (877) 247-4292 or (212) 983-9330.
Attorney Advertising. (C) 2012 Faruqi & Faruqi, LLP. The law
firm responsible for this advertisement is Faruqi & Faruqi, LLP
(www.faruqilaw.com). Prior results do not guarantee or predict a
similar outcome with respect to any future matter. We are happy to
discuss your particular case.
Biomimetic Therapeutics, Inc. (MM) (NASDAQ:BMTI)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Biomimetic Therapeutics, Inc. (MM) (NASDAQ:BMTI)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Biomimetic Therapeutics, Inc. (MM) (NASDAQ): 0 recent articles
Plus d'articles sur Faruqi & Faruqi, LLP